Overview
Ian Garrahy is a Hematologist and an Oncologist in Yardley, Pennsylvania. Dr. Garrahy is rated as an Advanced provider by MediFind in the treatment of Iron Deficiency Anemia. His top areas of expertise are Iron Deficiency Anemia, Acute Myelomonocytic Leukemia, Thrombocytopenia, Pulmonary Embolism, and Mastoidectomy. Dr. Garrahy is currently accepting new patients.
His clinical research consists of co-authoring 9 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- PPO
- EPO
- HMO
- PPO
- MEDICARE SNP
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
777 Township Line Road, Suite 210, Yardley, PA 19067
Additional Areas of Focus
Dr. Garrahy has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Salib Oncology
Hayman Salib is a Hematologist and an Oncologist in Easton, Pennsylvania. Dr. Salib is rated as a Distinguished provider by MediFind in the treatment of Iron Deficiency Anemia. His top areas of expertise are Glossitis, Pernicious Anemia, Vitamin B12 Deficiency, and RUNX1 Familial Platelet Disorder.
Penn Hematology/Oncology Bucks County
John Youssef is a Hematologist and an Oncologist in Yardley, Pennsylvania. Dr. Youssef is rated as a Distinguished provider by MediFind in the treatment of Iron Deficiency Anemia. His top areas of expertise are Iron Deficiency Anemia, Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, and Pleuropulmonary Blastoma. Dr. Youssef is currently accepting new patients.
LVH Hematology Oncology-Pocono
Philosophy of care | Having been on the receiving end of multiple cancer diagnoses within my own family as I grew up, I strongly believe my patients and their families have the right to an honest discussion about their disease process. I personally make every effort to explain things in a simple yet detailed way, so patients understand their disease, goals of care and treatment plan. I want to be a trusted partner in helping them deal with their diagnosis, and make every effort to treat each patient as I would a family member. | Why I entered medicine | My family suffers from a genetic syndrome that predisposes them to developing cancer. Having grown up watching and helping most of the people I love deal with cancer, I decided to study medicine and do what I could to improve treatment and help others live their best possible lives with this disease. After medical school, I did basic science research at Johns Hopkins University, followed by residency and fellowship training at the Cleveland Clinic and the University of Pittsburgh, all to become the best oncologist I could be. | Community involvement | I am involved in organizations and charities that improve the lives and treatment of cancer patients. I also help provide free specialized remote care and expert opinion to international patients in collaboration with their local health care providers. I enjoy community events to educate people on targeted therapies and their success in making cancer a chronic disease. I also enjoy giving talks on how oncology is evolving and how cancer today often means patients living full lives while being treated for their disease. | Personal interests | Outside of work, I love to spend time with my family and our two dogs. Together we enjoy cooking, traveling, trying new cuisines and being outdoors. I also enjoy hunting and fishing. Dr. Ali is rated as a Distinguished provider by MediFind in the treatment of Iron Deficiency Anemia. His top areas of expertise are Familial Colorectal Cancer, Anal Cancer, Colorectal Cancer, and Lynch Syndrome.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Iron Deficiency AnemiaDr. Garrahy isAdvanced. Learn about Iron Deficiency Anemia.
- Experienced
- Acquired AgranulocytosisDr. Garrahy isExperienced. Learn about Acquired Agranulocytosis.
- Acute Myelomonocytic LeukemiaDr. Garrahy isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Adult Immune ThrombocytopeniaDr. Garrahy isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Garrahy isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Garrahy isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Garrahy isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.


